Please wait while the formulary information is being retrieved.
TERAZOSIN HCL (TERAZOSIN HCL)
- Benign prostatic hyperplasia with lower urinary tract sx
- Hypertension
1 mg capsule
- 1 capsule (1 mg) by oral route once daily at bedtime
10 mg capsule
- 1 capsule (10 mg) by oral route once daily at bedtime
2 mg capsule
- 1 capsule (2 mg) by oral route once daily at bedtime
5 mg capsule
- 1 capsule (5 mg) by oral route once daily at bedtime
terazosin 1 mg capsule
- 1 capsule (1 mg) by oral route once daily at bedtime
terazosin 10 mg capsule
- 1 capsule (10 mg) by oral route once daily at bedtime
terazosin 2 mg capsule
- 1 capsule (2 mg) by oral route once daily at bedtime
terazosin 5 mg capsule
- 1 capsule (5 mg) by oral route once daily at bedtime
1 mg capsule
- 1 capsule (1 mg) by oral route once daily at bedtime
10 mg capsule
- 1 capsule (10 mg) by oral route once daily at bedtime
2 mg capsule
- 1 capsule (2 mg) by oral route once daily at bedtime
5 mg capsule
- 1 capsule (5 mg) by oral route once daily at bedtime
Benign prostatic hyperplasia with lower urinary tract sx
- 1 capsule (1 mg) by oral route once daily at bedtime
- 2 capsules (2 mg) by oral route once daily at bedtime
- 1 capsule (2 mg) by oral route once daily at bedtime
- 1 capsule (5 mg) by oral route once daily at bedtime
- 2 capsules (10 mg) by oral route once daily at bedtime
- 1 capsule (10 mg) by oral route once daily at bedtime
- 2 capsules (20 mg) by oral route once daily at bedtime
Hypertension
- 1 capsule (1 mg) by oral route once daily at bedtime
- 2 capsules (2 mg) by oral route once daily at bedtime
- 1 capsule (2 mg) by oral route once daily at bedtime
- 2 capsules (4 mg) by oral route once daily at bedtime
- 1 capsule (5 mg) by oral route once daily at bedtime
- 2 capsules (10 mg) by oral route once daily at bedtime
- 1 capsule (10 mg) by oral route once daily at bedtime
- 2 capsules (20 mg) by oral route once daily at bedtime
- None
Contraindicated
- None
Severe
Moderate
- acebutolol
- Adcirca
- atenolol
- atenolol-chlorthalidone
- avanafil
- betaxolol
- Betimol
- brimonidine-timolol
- Calan
- Calan Sr
- Cialis
- Combigan
- Corgard
- Corzide
- Cosopt
- Cosopt Pf
- dorzolamide-timolol
- dorzolamide-timolol (PF)
- Dutoprol
- Inderal La
- Inderal Xl
- Innopran Xl
- Istalol
- Levitra
- Lopressor
- Lopressor Hct
- metoprolol su-hydrochlorothiaz
- metoprolol succinate
- metoprolol ta-hydrochlorothiaz
- metoprolol tartrate
- nadolol
- nadolol-bendroflumethiazide
- pindolol
- propranolol
- propranolol-hydrochlorothiazid
- Revatio
- Sectral
- sildenafil
- Stendra
- tadalafil
- Tarka
- Tenoretic 100
- Tenoretic 50
- Tenormin
- timolol
- timolol maleate
- timolol maleate (PF)
- Timoptic
- Timoptic Ocudose (pf)
- Timoptic-xe
- Toprol Xl
- trandolapril-verapamil
- vardenafil
- verapamil
- Verelan
- Verelan Pm
- Viagra
- None
Contraindicated
- Orthostatic hypotension
- Priapism
Severe
Moderate
- Cataract surgery
- Intraoperative floppy iris syndrome
TERAZOSIN HCL (TERAZOSIN HCL)
- Benign prostatic hyperplasia with lower urinary tract sx
- Hypertension
- Dizziness
- General weakness
- Headache disorder
- Weight gain
More Frequent
Severe
Less Severe
- Angina
- Dyspnea
- Orthostatic hypotension
- Palpitations
- Peripheral edema
- Sinusitis
- Tachycardia
- Arthralgias
- Back pain
- Blurred vision
- Drowsy
- Hypotension
- Nasal congestion
- Nausea
- Paresthesia
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Atrial fibrillation
- Intraoperative floppy iris syndrome
- Priapism
- Thrombocytopenic disorder
Less Severe
- Erectile dysfunction
- Libido changes
- Vertigo
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Terazosin
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Terazosin Hydrochloride
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Terazosin
Use with caution, molecular wt low enough for possible breastmilk excretion
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Use with caution, molecular wt low enough for possible breastmilk excretion |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Terazosin
Cardiovascular-Orthostatic hypotension during the first few days of dosing may predispose to increased falls. Avoid if syncope is due to orthostasis. Consider alternative agent for treating hypertension. Urogenital-May aggravate urinary incontinence in women, avoid in women.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | Y | N | N |
BEERS: Y HEDIS: N STOPP: Y
No Known Risk
None
- None
| Benign prostatic hyperplasia with lower urinary tract sx | |
| N40.1 | Benign prostatic hyperplasia with lower urinary tract symptoms |
| Hypertension | |
| I10 | Essential (primary) hypertension |
| I11 | Hypertensive heart disease |
| I11.0 | Hypertensive heart disease with heart failure |
| I11.9 | Hypertensive heart disease without heart failure |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I15.1 | Hypertension secondary to other renal disorders |
| 0-9 | A-Z |
|---|---|
| I10 | Essential (primary) hypertension |
| I11 | Hypertensive heart disease |
| I11.0 | Hypertensive heart disease with heart failure |
| I11.9 | Hypertensive heart disease without heart failure |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I15.1 | Hypertension secondary to other renal disorders |
| N40.1 | Benign prostatic hyperplasia with lower urinary tract symptoms |
Formulary Reference Tool